Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TMEM69 pseudogene 2 (TMEM69P2)
- Target
- TMEM69P2
- Molecular classification
- Other (Pseudogene)
01
Overview
TMEM69P2, officially named TMEM69 pseudogene 2, is a human pseudogene. Pseudogenes are non-functional DNA sequences similar to known genes but generally do not produce functional proteins or have annotated molecular or disease roles. TMEM69P2 is not considered a therapeutic target and has no known function in cellular signaling, disease, or pharmacology. Its only relevance is as a genomic element, and it is not a target for drugs, nor does it act as a biomarker or pose safety concerns in therapeutic contexts. Information about alternative splicing, expression, or disease involvement is not available because it is a pseudogene and not functionally active[6].
- Other names
- TMEM69P2
Beyond the preview
Go deeper on TMEM69 pseudogene 2 (TMEM69P2).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TMEM69 pseudogene 2 (TMEM69P2).